MMP9 and pulmonary emphysema: Our study demonstrates the therapeutic potential of deflamin to attenuate the development of pulmonary emphysema and peribronchial fibrosis in mice chronically exposed to ozone through interacting and regulating the catalytic activity of MMP-9.